Nonatopic severe asthma might still be atopic: Sensitization toward Staphylococcus aureus enterotoxins - 06/06/19
![](/templates/common/images/mail.png)
The study was supported and funded by Novartis Pharma GmbH, Dr Claudia Mailänder. Medical writing services from Dr Maren Klug, employee of KW medipoint, were also funded by Novartis Pharma GmbH. |
|
Disclosure of potential conflict of interest: J. Schreiber reports personal fees and other fees from Novartis, during the conduct of the study; and grants from Novartis, personal fees from Novartis, and other fees from Novartis, outside the submitted work. B. M. Bröker reports grants from the German Research Foundation (DFG) and personal fees from Novartis Pharma, during the conduct of the study; and grants from the German Research Foundation (DFG), the German Ministry of Education and Research (BMBF), and the European Union, and personal fees from Pfizer, Inc, outside the submitted work. R. Ehmann reports grants from Novartis, during the conduct of the study; and grants from Novartis, GlaxoSmithKline, Teva, and AstraZeneca, outside the submitted work. C. Bachert reports consultancy fee and payment of lecture fees from Novartis, Sanofi, Astra Zeneca, and GlaxoSmithKline, outside the submitted work. |
Vol 143 - N° 6
P. 2279 - juin 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?